MKI67 and breast carcinoma: Moreover, in order to further validate the growth ability mediated by these miRNAs in vivo, the tumor tissues were removed from the killed nude mice for IHC staining with Ki67 antibody and the results were consistent with our guess that miR-106b or miR-93 overexpression enhanced the growth of breast cancer (Figure 4c).